InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-11.2%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Nissenson Allen, Director. Insider active across 2 companies, notably Rockwell Medical, INC.. Aggregated, 8 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €8k. Activity tracked since 17 June 2021. The latest transaction was filed on 1 July 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
9,633 shares0Common StockSEC:0001628280-26-047126:0
50,000 shares0Common StockSEC:0001104659-25-051713:0
36,111 shares0Common StockSEC:0001104659-24-064810:0
24,715 shares0Common StockSEC:0001104659-23-064638:0
25,000 shares0Common StockSEC:0001104659-22-069681:0
7,346 shares@ US$1.16100.0% of flowCommon StockSEC:0001628280-22-015238:0
Ideal exit: 13 Feb 2023 (T+270)
50,000 shares0Common StockSEC:0001628280-21-012667
50,000 shares0Common StockSEC:0001628280-21-012667:0
8 of 8 declarations
About Nissenson Allen
Allen Nissenson is a Board Member at ROCKWELL MEDICAL, INC. and Angion Biomedica Corp. He has extensive experience in the healthcare sector, enabling him to effectively contribute to the strategy and governance of the companies. His role as a Board Member includes overseeing performance and participating in strategic decisions. His expertise is essential for development and innovation.
